Paolo Confalonieri Selected Research

Phosphotransferases (Kinase)

1/2013	Complete stable remission and autoantibody specificity in myasthenia gravis.
8/2008	Two cases of thymoma-associated myasthenia gravis without antibodies to the acetylcholine receptor.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Paolo Confalonieri Research Topics

Disease

8	Multiple Sclerosis 02/2022 - 09/2013
5	Myasthenia Gravis 01/2013 - 08/2003
4	Muscular Dystrophies (Muscular Dystrophy) 04/2006 - 11/2002
3	Inflammation (Inflammations) 12/2016 - 09/2003
3	Duchenne Muscular Dystrophy (Muscular Dystrophy, Becker) 04/2009 - 11/2002
3	Fibrosis (Cirrhosis) 06/2006 - 11/2002
2	COVID-19 07/2022 - 01/2022
2	Relapsing-Remitting Multiple Sclerosis 01/2021 - 01/2014
2	Myositis (Idiopathic Inflammatory Myopathies) 06/2008 - 09/2003
2	Thymus Hyperplasia 09/2003 - 08/2003
1	Paralysis (Palsy) 09/2013
1	Demyelinating Diseases (Demyelinating Disease) 09/2013
1	Experimental Autoimmune Encephalomyelitis (Encephalomyelitis, Autoimmune Experimental) 09/2013
1	Stiff-Person Syndrome (Stiff Man Syndrome) 01/2009
1	Isaacs Syndrome (Neuromyotonia) 01/2009
1	Thymoma (Thymic Carcinoma) 08/2008
1	Polymyositis 09/2003

Drug/Important Bio-Agent (IBA)

4	Proteins (Proteins, Gene)FDA Link 06/2008 - 11/2002
3	AntibodiesIBA 09/2013 - 08/2008
3	Transforming Growth Factor beta1 (TGF beta 1)IBA 06/2006 - 11/2002
2	Immunoglobulin G (IgG)IBA 02/2022 - 09/2013
2	Immunosuppressive Agents (Immunosuppressants)IBA 02/2022 - 02/2005
2	muskIBA 01/2013 - 08/2008
2	Phosphotransferases (Kinase)IBA 01/2013 - 08/2008
2	Cholinergic ReceptorsIBA 01/2013 - 08/2008
2	AntioxidantsIBA 04/2009 - 04/2006
1	Methylprednisolone FDA LinkGeneric 07/2022
1	BNT162 VaccineIBA 02/2022
1	VaccinesIBA 02/2022
1	Air Pollutants (Pollutants, Air)IBA 01/2022
1	Particulate MatterIBA 01/2022
1	PlatinumIBA 01/2021
1	InterferonsIBA 01/2021
1	N-formylmethionylphenylalanine (FMP)IBA 11/2019
1	DNA (Deoxyribonucleic Acid)IBA 01/2014
1	AutoantibodiesIBA 01/2013
1	Azathioprine (Imuran)FDA LinkGeneric 01/2013
1	thiopurine methyltransferase (thiopurine S-methyltransferase)IBA 01/2013
1	Pentoxifylline (Trental)FDA LinkGeneric 04/2009
1	Phosphoric Diester Hydrolases (Phosphodiesterases)IBA 04/2009
1	Potassium Channels (Potassium Channel)IBA 01/2009
1	KinesinsIBA 06/2008
1	DystrophinIBA 06/2006
1	Neutralizing AntibodiesIBA 06/2006
1	calpain inhibitorsIBA 04/2006
1	Creatine Kinase (Creatine Phosphokinase)IBA 02/2005
1	DysferlinIBA 09/2003
1	Cholinesterase Inhibitors (Anticholinesterases)IBA 08/2003
1	Messenger RNA (mRNA)IBA 11/2002
1	Connective Tissue Growth FactorIBA 11/2002
1	CollagenIBA 11/2002
1	CytokinesIBA 11/2002

Therapy/Procedure

4	Therapeutics 02/2022 - 04/2009
3	Palliative Care (Palliative Therapy) 04/2021 - 04/2015
2	Thymectomy 09/2003 - 08/2003
1	Injections 01/2021
1	Plasma Exchange 01/2009
1	Immunomodulation 06/2006